Folia Microbiologica

, Volume 64, Issue 2, pp 133–141 | Cite as

Alternative and complementary therapies for vulvovaginal candidiasis

  • Thais Chimati FelixEmail author
  • Denise Von Dolinger de Brito Röder
  • Reginaldo dos Santos Pedroso


When it comes to women’s health, treating vaginal infections makes up a high proportion of the gynecological services. Among the forms of vaginitis, vulvovaginal candidiasis (VVC) is considered the second most common. Demand for new treatment alternatives is increasingly relevant, especially for therapies with fewer side effects, better tolerability, and lower cost, while still offering improved quality of life in terms of disease prevention. This study intended to investigate the alternative therapies described for the adjuvant treatment of vulvovaginitis caused by Candida species, including alternative and complementary treatment methods used by women. This literature review is based on articles written in English and Portuguese in the PubMed, Google Scholar, and SciELO databases. This study was conducted for the most part using the Brazilian Government’s Capes Periodicals Portal, which directs to Google Scholar and PubMed. Since the 1980s, there has been growing interest in alternative therapies in Brazil, a trend which also began in other Western countries in the second half of the twentieth century. Some alternative treatments include substances with antifungal activity, some substances help restore the balance of the vaginal microbiota, while others have an inhibitory activity on microbial virulence factors. The proper use of therapeutic alternatives can effectively contribute to the treatment of VVC, but it should be remembered that some chemical products, such as boric acid or vinegar, and even natural products such as propolis, garlic, and tea tree may have undesirable side effects, having not been tested by well-designed clinical studies. Even so, alternative therapies in the treatment of VVC do have support in the scientific literature.



The authors are grateful to FAPEMIG (Fundação de Amparo a Pesquisa do Estado de Minas Gerais, Brazil), call announcement 001/2017, for the award of a master’s degree scholarship to TC Felix.

Compliance with ethical standards

Conflict of interests

The authors declare that they have no conflicts of interests.


  1. Abbas AM, Shaaban OM, Badran SM et al (2016) Risk factors and health hazards of vaginal infections in upper Egypt: a cross sectional study. Thai J Obstet Gynecol 24:50–56Google Scholar
  2. Bahadoran P, Rokni FK, Fahami F (2010) Investigating the therapeutic effect of vaginal cream containing garlic and thyme compared to clotrimazole cream for the treatment of mycotic vaginitis. Iran J Nurs Midwifery Res 15(Suppl1):343–349Google Scholar
  3. Bernardo KMR, Lima APW (2015) Candidiasis within cytological tests of patients’ at Hospital Geral de Curitiba. Rev Saúde e Desenvolvimento 8(4):198–206Google Scholar
  4. Brandolt TM, Klafke GB, Gonçalves CV et al (2007) Prevalence of Candida spp. in cervical-vaginal samples and the in vitro susceptibility of isolates. Braz J Microbio 48(1):145–150CrossRefGoogle Scholar
  5. Brasil (2012). Práticas integrativas e complementares: plantas medicinais e fitoterapia na Atenção Básica. Ministério da Saúde. Accessed 19 January 2018
  6. Bunick CG, Lott JP, Warren CB, Galan A, Bolognia J, King BA (2012) Chemical burn from topical apple cider vinegar. J Am Acad Dermatol 67(4):e143–e144CrossRefGoogle Scholar
  7. Capoci IRG, Bonfim-Mendonça OS, Arita GS et al (2015) Propolis is an efficient fungicide and inhibitor of biofilm production by vaginal Candida albicans. Evid Based Complement Alternat Med 2015:1–9CrossRefGoogle Scholar
  8. Centers for Disease Control and Prevention (CDC) (2015). Sexually transmitted diseases treatment guidelines. Accessed 19 November 2017
  9. Colombo AL, Guimarães T, Camargo LFA, Richtmann R, de Queiroz-Telles F, Salles MJC, da Cunha CA, Yasuda MAS, Moretti ML, Nucci M (2013) Brazilian guidelines for the management of candidiasis - a joint meeting report of three medical societies: Sociedade Brasileira de Infectologia, Sociedade Paulista de Infectologia and Sociedade Brasileira de Medicina Tropical. Braz J Infect Dis 17(3):283–312CrossRefGoogle Scholar
  10. Costa ACBP, Teodoro GR, Ferreira T et al (2010) Antifungal activity of Melaleuca alternifolia essential oil on yeasts isolated from HIV positive pregnant women with oral candidiasis. Rev Inst Adolfo Lutz 69(3):40–407Google Scholar
  11. Cruz PL, Sampaio SF (2016) The unconventional therapeutic practices in health care: integrative review. Rev APS 19(3):483–494Google Scholar
  12. Darvishi M, Jahdi F, Hamzegardeshi Z, Goodarzi S, Vahedi M (2015) The comparison of vaginal cream of mixing yogurt, honey and clotrimazole on symptoms of vaginal candidiasis. Glob J Health Sci 7(6):108–116CrossRefGoogle Scholar
  13. De Rossi T, Lozovoy M, Silva R et al (2011) Interactions between Candida albicans and host. Semina: Ciências Biológicas e da Saúde 32(1):15–28Google Scholar
  14. De Seta FS, Schmidt M, Vu B et al (2009) Antifungal mechanisms supporting boric acid therapy of Candida vaginitis. J Antimicrob Chemother 63:325–336CrossRefGoogle Scholar
  15. Donders G, Ruban K, Bellen G (2015) Selecting anti-microbial treatment of aerobic vaginitis. Curr Infect Dis Rep 17(5):477CrossRefGoogle Scholar
  16. Ebrahimy F, Dolatian M, Moatar F, Alavi Majd H (2015) Comparison of the therapeutic effects of Garcin® and fluconazole on Candida vaginitis. Singap Med J 56(10):567–572CrossRefGoogle Scholar
  17. Falagas ME, Betsi GI, Athanasiou S (2006) Probiotics for prevention of recurrent vulvovaginal candidiasis: a review. J Antimicrob Chemother 58(2):266–272CrossRefGoogle Scholar
  18. Feuerschuette OHM, Silveira SK, Feuerschuette I et al (2010) Recurrent vaginal candidiasis: clinical management. Femina 38(2):31–36Google Scholar
  19. Florianópolis (2016). Protocolo de Enfermagem Volume 3. Saúde da Mulher, acolhimento às demandas da mulher nos diferentes ciclos de vida. Accessed 03 July 2018
  20. Fonseca GM, Passos TC, Ninahuaman MFML, Caroci AS, Costa LS (2014) Evaluation of the antimicrobial activity of garlic (Liliaceae Allium sativum) and its aqueous extract. Rev Bras Pl Med 16(3):679–684CrossRefGoogle Scholar
  21. Fule SR, Das D, Fule RP (2015) Detection of phospholipase activity of Candida albicans and non-albicans isolated from women of reproductive age with vulvovaginal candidiasis in rural area. Indian J Med Microbiol 33(1):92–95CrossRefGoogle Scholar
  22. Garcia-Elorriaga G, Rey-Pineda G (2013) Nutrition and intestinal microflora. J Nutr Ther 2:112–121Google Scholar
  23. Guaschino S, De Seta F, Sartore A et al (2001) Efficacy of maintenance therapy with topical boric acid in comparison with oral itraconazole in the treatment of recurrent vulvovaginal candidiasis. Am J Obstet Gynecol 184(4):598–602CrossRefGoogle Scholar
  24. Gunther LSA, Martins HPR, Gimenes F, Abreu ALP, Consolaro MEL, Svidzinski TIE (2014) Prevalence of Candida albicans and non-albicans isolates from vaginal secretions: comparative evaluation of colonization, vaginal candidiasis and recurrent vaginal candidiasis in diabetic and non-diabetic women. São Paulo Med J 132(2):116–120CrossRefGoogle Scholar
  25. Happel AU, Jaumdally SZ, Pidwell T et al (2017) Probiotics for vaginal health in South Africa: what is on retailers’ shelves? BMC Womens Health 17(7):1–10Google Scholar
  26. Hoekstra M, Westgate S, Mueller S (2017) Povidone-iodine ointment demonstrates in vitro efficacy against biofilm formation. Int Wound J 14(1):172–179CrossRefGoogle Scholar
  27. Ismail AM, Abbas AM, Shams AH et al (2017) The effect of use of vaginal Lactobacillus rhamnosus for prevention of recurrence of vulvovaginal candidiasis; a randomized controlled trial. Thai J Obstet Gynaecol 25(1):62–68Google Scholar
  28. Kanagalingam J, Feliciano R, Hah JH et al (2015) Practical use of povidone-iodine antiseptic in the maintenance of oral health and in the prevention and treatment of common oropharyngeal infections. Int J Clin Pract 69(11):1247–1256CrossRefGoogle Scholar
  29. Kondo S, Tabe Y, Yamada T, Misawa S, Oguri T, Ohsaka A, Miida T (2011) Comparison of antifungal activities of gentian violet and povidone-iodine against clinical isolates of Candida species and other yeasts: a frame work to establish topical disinfectant activities. Mycopathologia 173(1):21–25CrossRefGoogle Scholar
  30. Lavazzo C, Gkegkes LD, Zarkada LM et al (2011) Boric acid for recurrent vulvovaginal candidiasis: the clinical evidence. J Women’s Health (Larchmt) 20(8):1245–1255CrossRefGoogle Scholar
  31. Leão MVP, Silva CRG, Santos SSF et al (2015) Lactobacillus rhamnosus may change the virulence of Candida albicans. Rev Bras Ginecol Obstet 37(9):417–420CrossRefGoogle Scholar
  32. Leite Júnior DP, Martins ER, Hahn RC et al (2011) Species of Candida isolated from anatomically distinct sites in military personnel in Cuiabá, Mato Grosso, Brazil. An Bras Dermatol 86(4):675–6780CrossRefGoogle Scholar
  33. Lima CF, Bernuci KZ, Moreschi ARC (2013) Atividade antifúngica do óleo essencial de Melaleuca Alternifolia (tea tree) sobre leveduras do gênero Candida da cavidade bucal. In: Encontro Internacional de Produção Cientifica, 8; 2013, Maringá. Anais Eletrônico, Maringá: Cesumar, p. 1–5. Accessed 14 February 2018
  34. Lopes NS, Conde BE, Fonseca AS et al (2016) Medicina complementar e alternativa no contexto da ayurveda e da medicina popular no Brasil. Persp Online: Biol &Saúde 20(6):30–44Google Scholar
  35. Lupion GCA, Camacho DP, Negri M (2013) In vitro evaluation of excerpt from propolis as possible source of treatment for vulvovaginal candidiasis. Braz J Surg Clin Res 4(2):11–16Google Scholar
  36. Matsubara VH, Bandaram HMHN, Mayer MP et al (2016) Probiotics as antifungals in mucosal candidiasis. Clin Infect Dis 62(9):1143–1153CrossRefGoogle Scholar
  37. Martins N, Ferreira ICFR, Barros L et al (2010) Candidiasis: predisposing factors, prevention, diagnosis and alternative treatment. Mycopathologia 177(5):223–240Google Scholar
  38. Mertas A, Garbusinska A, Szliszka E et al (2015) The influence of tea tree oil (Melaleuca alternifolia) on fluconazole activity against fluconazole-resistant Candida albicans strains. Biomed Res Int 2015:1–9CrossRefGoogle Scholar
  39. Miró MS, Rodríguez E, Vigezzi C, Icely PA, Gonzaga de Freitas Araújo M, Riera FO, Vargas L, Abiega C, Caeiro JP, Sotomayor CE (2017) Vulvovaginal candidiasis: an old disease with new challenges. Rev Iberoam Micol 34(2):65–71CrossRefGoogle Scholar
  40. Mullins MZ, Trouton KM (2015) BASIC study: is intravaginal boric acid non-inferior to metronidazole in symptomatic bacterial vaginosis? Study protocol for a randomized controlled trial. Trials 16(315):1–7Google Scholar
  41. Nascimento MS, Silva N, Catanozi MPLM et al (2003) Effects of different disinfection treatments on the natural microbiota of lettuce. J Food Prot 66(9):1697–1700CrossRefGoogle Scholar
  42. Naud P, Matos JC, Stuczynski JV et al (2007) Doenças sexualmente transmissíveis. In: Ramos JGL, Martins-Costa SH, Barros E, Machado A (eds) Antimicrobianos em Ginecologia e Obstetrícia: Consulta Rápida. Porto Alegre, Artmed, pp 95–118Google Scholar
  43. Ninomiya K, Maruyama N, Inoue S, Ishibashi H, Takizawa T, Oshima H, Abe S (2012) The essential oil of Melaleuca alternifolia (tea tree oil) and its main component, terpinen-4-ol protect mice from experimental oral candidiasis. Biol Pharm Bull 35(6):861–865CrossRefGoogle Scholar
  44. Nyirjesy P, Robinson J, Mathew L, Lev-Sagie A, Reyes I, Culhane JF (2011) Alternative therapies in women with chronic vaginitis. Obstet Gynecol 117(4):856–861CrossRefGoogle Scholar
  45. Nyirjesy P, Weitz MV, Grody MH et al (1999) Over-the-counter and alternative medicines in the treatment of chronic vaginal symptoms. Obstet Gynecol 90(1):50–53CrossRefGoogle Scholar
  46. Oliveira-Júnior JK, Vieira LEM, Barnabé LEG et al (2017) Analysis of antifungal effect of propolis on species of Candida albicans and non-albicans. Revista Uningá 30(3):45–51Google Scholar
  47. Pappas PG, Kauffman CA, Andes D, Benjamin DK Jr, Calandra TF, Edwards JE Jr, Filler SG, Fisher JF, Kullberg BJ, Ostrosky-Zeichner L, Reboli AC, Rex JH, Walsh TJ, Sobel JD, Infectious Diseases Society of America (2009) Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis 48(5):503–535CrossRefGoogle Scholar
  48. Papa R, Troncone MG, Altruda F, Rullo V, Saponati G (2017) Clinical evaluation of the efficacy and safety of a medical vaginal device containing Rigenase® for the treatment of vaginosis: a randomized study. J Clin Gynecol Obstet 6(1):6–11CrossRefGoogle Scholar
  49. Petersen EE, Weissenbacher ER, Hengst P, Spitzbart H, Weise W, Wolff F, Dreher E, Ernst U, Della Casa V, Pohlig G, Graf F, Kaiser RR (2002) Local treatment of vaginal infections of varying etiology with dequalinium chloride or povidone iodine. A randomised, double-blind, active-controlled, multicentric clinical study. Arzneimittelforschung 52(9):706–715Google Scholar
  50. Pinto TMS, Neves ACC, Leão MVP, Jorge AOC (2008) Vinegar as an antimicrobial agent for control of Candida spp. in complete denture wearers. J Appl Oral Sci 16(6):385–390CrossRefGoogle Scholar
  51. Pirotta MV, Gunn JM, Chondros P (2003) “Not thrush again!” Women’s experience of post-antibiotic vulvovaginitis. Med J Aust 179(1):43–46Google Scholar
  52. Pointer BR, Bover MP, Schmidt M (2015) Boric acid destabilizes the hyphal cytoskeleton and inhibits invasive growth of Candida albicans. Yeast 32(4):389–398CrossRefGoogle Scholar
  53. Reid G, Jass J, Sebulsky MT, McCormick JK (2003) Potential uses of probiotics in clinical practice. Clin Microbiol Ver 16(4):658–672CrossRefGoogle Scholar
  54. Rodrigues MT, Simões LZ, Diniz CG (2009) Clinical, microbiological and therapeutic aspects of vulvovaginal candidiasis and recurrent vulvovaginal candidiasis: importance of regional surveys. HU Rev 35(3):175–181Google Scholar
  55. Santos CMA, Pires MCV, Leão TL et al (2016) Selection of Lactobacillus strains as potential probiotics for vaginitis treatment. Microbiology 126(7):1195–1207Google Scholar
  56. Santos CMA, Pires MCV, Leão TL, Silva AKS, Miranda LS, Martins FS, Silva AM, Nicoli JR (2018) Anti-inflammatory effect of two Lactobacillus strains during infection with Gardnerella vaginalis and Candida albicans in a HeLa cell culture model. Microbiology 164(3):349–358CrossRefGoogle Scholar
  57. Secor WE (2010) Trichomonas vaginalis: treatment questions and challenges. Expert Rev Anti-Infect Ther 10(2):107–109CrossRefGoogle Scholar
  58. Sexual Health Medicine (2018) Treatment of vulvovaginal candidiasis. Accessed on 26 January 2018
  59. Shaaban OM, Abbas AM, Moharram AM, Farhan MM, Hassanen IH (2015) Does vaginal douching affect the type of candidal vulvovaginal infection? Med Mycol 53:817–827CrossRefGoogle Scholar
  60. Soares R, Vieira-Baptista P, Tavares S (2017) Cytolytic vaginosis: an underdiagnosed pathology that mimics vulvovaginal candidiasis. Acta Obstet Ginecol Port 11(2):106–112Google Scholar
  61. Sobel JD, Chaim W, Nagappan V, Leaman D (2003) Treatment of vaginitis caused by Candida glabrata: use of topical boric acid and flucytosine. Am J Obstet Gynecol 189(5):1297–1300CrossRefGoogle Scholar
  62. Sobel JD, Chaim W (1997) Treatment of Torulopsis glabrata vaginitis: retrospective review of boric acid therapy. Clin Infect Dis 24(4):649–652CrossRefGoogle Scholar
  63. Sociedade Portuguesa de Ginecologia (2012). Revisão dos consensos em infecções vulvovaginais. Accessed 06 November 2017
  64. Streicher, LF, Zar FA (1993) Chronic Vaginites. In: Knaus V, Isaacs JH, (ed) Office gynecology: advanced management concepts. Springer-Verlag; pp 30–48Google Scholar
  65. Van der Meijden WI, Piot P, Schmitz PIM et al (1987) Treatment of clue cell-positive discharge with 200 mg povidone-iodine pessaries. A double-blind and placebo-controlled trial. Eur J Obstet Gynecol Reprod Biol 24(4):299–307CrossRefGoogle Scholar
  66. Wagner RD, Johnson SJ (2012) Probiotic lactobacillus and estrogen effects on vaginal epithelial gene expression responses to Candida albicans. J Biomed Sci 19(1):84CrossRefGoogle Scholar
  67. Watson C, Calabretto H (2007) Comprehensive review of conventional and non-conventional methods of management of recurrent vulvovaginal candidiasis. Aust N Z J Obstet Gynaecol 47(4):262–272CrossRefGoogle Scholar
  68. Watson CJ, Grando D, Fairley CK, Chondros P, Garland SM, Myers SP, Pirotta M (2014) The effects of oral garlic on vaginal candida colony counts: a randomised placebo controlled double-blind trial. BJOG 121(4):498–506CrossRefGoogle Scholar
  69. Wewalka G, Stary A, Bosse B, Duerr HE, Reimer K (2002) Efficacy of povidone-iodine vaginal suppositories in the treatment of bacterial vaginosis. Dermatology 204(suppl.1):79–85CrossRefGoogle Scholar
  70. Wong R, Wong V, Hung E et al (2011) Topical application of povidone-iodine before wound closure is associated with significant increase in serum iodine levels. Surg Pract 15(3):79–82CrossRefGoogle Scholar
  71. Zahedi N, Abedian KS, Mohseni S et al (2016) Is human Dectin-1 Y238X gene polymorphism related to susceptibility to recurrent vulvovaginal candidiasis? Curr Med Mycol 2(3):15–19CrossRefGoogle Scholar

Copyright information

© Institute of Microbiology, Academy of Sciences of the Czech Republic, v.v.i. 2018

Authors and Affiliations

  1. 1.Postgraduate Program in Health Sciences, Faculty of MedicineFederal University of UberlandiaUberlandiaBrazil
  2. 2.Postgraduate Program in Health Sciences, Faculty of Medicine and Institute of Biomedical SciencesFederal University of UberlandiaUberlandiaBrazil
  3. 3.Postgraduate Program in Health Sciences, Faculty of Medicine and Clinical Analysis Technical Course, Health Technical SchoolFederal University of UberlandiaUberlandiaBrazil

Personalised recommendations